Provention Bio receives notice of allowance from USPTO for patent on multi-strain coxsackievirus B vaccine for preventing or treating type 1 diabetes (T1D)
Monday, January 28, 2019 DrugName : PRV-101 Provention Bio is developing PRV-101 as a vaccine for acute coxsackie virus infection
Read More